Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Completed · Not applicable

Conditions studied: Sarcoma, Lung, Solid Tumor Gastrointestinal

In brief

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Key facts

Study ID

NCT02833246

Run by

Memorial Sloan Kettering Cancer Center

People needed

28

Starts

2016-06-28

Expected to finish

2018-11-14

Last updated by the study team

2018-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
• Starting a new treatment regimen that includes a single oral anticancer medication
• Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
• Age 18 or older.
• Ability to speak and read English because we do not have the resources to translate the text messages into other languages.

You may not qualify if…

• Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.